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ABSTRACT 
 
Background: Approximately 15 % of all couples in the Western countries experience infertility. Up 
to half of these cases are thought to solely or partly depend upon the male factor. In most cases male 
infertility is unexplained. During the last decade there has been a growing focus on sperm DNA 
damage as a cause of male infertility. Sperm chromatin structure assay (SCSA) is increasingly used to 
evaluate male fertility status as it determines sperm DNA damage. This DNA damage can originate 
from several sources, the major being oxidative stress, i.e excess of reactive oxygen species (ROS). 
Increased ROS may be a result of different factors, for instance chronic diseases, infections or lifestyle 
factors such as smoking and high body mass index (BMI). Despite this, sperm ROS is not tested for in 
routine infertility assessment. A new promising analysis for assessing sperm ROS production is the 
nitro blue tetrazolium assay (NBT).  
Objectives: The primary objective was to study the correlation between sperm oxidative stress 
assessed with NBT assay and sperm DNA fragmentation index (DFI) assessed with SCSA in 
subfertile men. Secondly, the objective was to correlate these parameters to BMI as well as to the level 
of serum testosterone. 
Method: The prospective study was conducted on a cohort of forty-seven subfertile men. To assess 
sperm quality the NBT assay, SCSA and World Health Organization (WHO) sperm analysis were 
performed. For all men testosterone, lutenizing hormone (LH) and BMI were measured. 
Result: There was a tendency to a correlation between NBT outcome and DFI (n = 39, r = 0.281, P = 
0.084), however not statistically significant. Men with a BMI > 30 kg/m
2 
had an increased risk for 
having a DFI > 30% (OR = 8.6, P = 0.070) compared to the normal weighted men, although not 
statistically significant.  
Conclusion: There was a weak association between sperm oxidative stress and sperm DNA damage. 
A high BMI was correlated to an increased risk of DNA damage. Although non of these findings were 
statistically significant they show the same tendencies as previous reports. Sperm oxidative stress 
seems likely as a cause of male infertility and large scale clinical trials are warranted to further 
evaluate the NBT assay. The hope for the future is to be able to sort out the men with sperm oxidative 
stress caused infertility, who potentially would benefit from antioxidant strategies. 
 
 
 
 
 
 
 
 
Master thesis, LÄKM01, 2012/2013  B.Bergström, S.Jarkman 
3 
 
POPULÄRVETENSKAPLIG SAMMANFATTNING 
 
Av alla par i västvärlden drabbas ungefär 15 % av ofrivillig barnlöshet. I upp till hälften av fallen är 
orsaken eller en bidragande orsak den manliga faktorn, som i många fall inte kan förklaras med 
dagens rutinspermaundersökningar. Standardmetoden för spermieanalys, utarbetad av World Health 
Organization (WHO), har i flertalet studier visat sig vara ett bristfälligt sätt att förutsäga förmågan att 
få barn. På senare år har teorier framkommit om att oxidativ stress, det vill säga ett överskott av fria 
syreradikaler, kan bidra till eller orsaka manlig infertilitet.  
 
Fria syreradikaler finns naturligt i låg koncentration i sperma men när de ökar i mängd och överstiger 
antioxidationsförsvaret uppstår vad man kallar oxidativ stress. Den oxidativa stressen skadar bland 
annat spermiernas DNA och försvårar eller omöjliggör befruktningen av ägget och därmed graviditet. 
En ökning av fria radikaler har man bland annat sett vid fetma, större alkoholintag, rökning, efter intag 
av vissa mediciner, exponering av föroreningar och vid vissa sjukdomar.  
 
Vårt huvudsakliga syfte var att studera sambandet mellan oxidativ stress i spermier, DNA-skada i 
spermier och fertilitet. Därför undersökte vi 47 stycken män med känd nedsatt fertilitet. Männen 
undersöktes med avseende hur mycket oxidativ stress deras spermier innehöll, mätt med nitro blue 
tetrazolium assay (NBT). Männen undersöktes även med avseende på hur skadat deras spermie-DNA 
var, mätt med sperm chromatin structure assay (SCSA).  Könshormonsnivåer i blodet mättes och body 
mass index (BMI) beräknades. Vi fann ett svagt samband mellan oxidativ stress och DNA-skada i 
spermier. I tidigare studier har detta samband fastställts och varit betydligt starkare. Vi såg också, 
dock även detta osäkert, att grav övervikt ökar risken för att ha DNA-skada i spermierna.    
 
Nitro blue tetrazolium assay är en ny, lovande metod för att mäta oxidativ stress i spermier, men fler 
studier krävs för att metoden ska kunna etablera sig i rutinmässig infertilitetsutredning. Förhoppningen 
är att man i framtiden ska kunna urskilja när oxidativ stress är en orsak till infertilitet. Då skulle man 
kunna avgöra vilka män som skulle kunna ha nytta av livsstilsförändringar och/eller behandling med 
antioxidanter, i syfte att normalisera spermiekvalitén. Vinsterna skulle då bli minskat lidande hos 
berörda och minskade ekonomiska kostnader. 
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1 INTRODUCTION 
 
Approximately 15 % of all couples in Western countries experience infertility, i.e. failure to conceive 
within a year of unprotected sexual intercourse, and up to half of all cases is believed to solely or 
partly depend upon the male factor (1, 2). Male infertility can have many possible causes, such as 
primary testicular dysfunction, genetic disorders and genital infections (3). However, due to limited 
diagnostic tools a significant number of men are diagnosed with unexplained infertility (2, 4, 5) and 
often treated symptomatically by assisted reproductive techniques (ART). This approach is invasive, 
costly and highly challenging for the couple as well as for the community.  
 
The traditional World Health Organization (WHO) semen analysis evaluates three sperm parameters; 
concentration, motility and morphology (6). Although the WHO analysis is recognized as the golden 
standard, its role as a predictor of male fertility has been questioned (7-10). Despite this no other 
analysis that address sperm quality is commonly used in routine (11). However, during the last decade 
the search for better predictors of fertility has contributed to a growing focus on sperm DNA integrity 
(Reviewed in (9, 12)). Although still many questions remain to be answered, it is evident that sperm 
DNA integrity is a valuable marker of male fertility (4, 13, 14). Sperm DNA integrity can be used 
alone or in combination with the conventional semen parameters, in natural conception as well as in 
ART to predict male fertility potential (4, 13, 14). 
 
1.1 Male infertility and sperm DNA damage  
Of the established causes of male infertility the most common is a primary testicular dysfunction that 
effects the sperm production and/or testosterone production (3). Other causes are genetic disorders, 
such as Klinefelters syndrome and microdeletion on the y-chromosome (3). Genital infections, for 
example chlamydia and gonorrhea, and endocrine disturbances, such as hypothalamus–pituitary–testis 
axis disturbances and diabetes, may also cause decreased fertility (15). Another acknowledged cause 
is when antibodies against sperm are formed for example following trauma, obstruction, infection and 
inflammation (15).  
 
Despite the many well-known causes, most of infertile men are diagnosed with idiopathic infertility 
(3, 4).  Although categorized as unexplained infertile, sperm DNA damage has been recognized as a 
possible explanation (4, 13, 16). Several studies has indicated that increased sperm DNA damage 
correspond well with reduced spontaneous conceptions (4, 16) and increases the risk of miscarriage 
(Reviewed in (17)).  
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The mechanisms behind DNA damage in the male germ line are not fully unraveled (18), however, 
four major causes are recognized: (a) DNA damage during spermatogenesis due to a defective 
checkpoint in the meiotic prophase. This may lead to continuation through meiosis although the DNA 
double strand breaks have not yet been fully repaired after the meiotic crossing-over. (b) DNA 
damage because of abnormal maturation of the spermatozoa (18). Two mechanisms have been 
proposed. Firstly, defective protamination may occur (9). In spermatogenesis histones are replaced by 
protamines which are essential for condensation and DNA stabilization in spermatozoa (19). 
Secondly, default ligation of transient DNA breaks may occur (9). Transient DNA breaks are required 
in the gamete´s evolvement, to relieve torsional stress and facilitate rearrangement of chromatin (9, 
20). (c) Sperm DNA damage due to abortive apoptosis, which is when apoptosis is initiated but 
impeded. Apoptotic biomarkers have been recorded in spermatozoa, mainly in spermatozoa of 
infertile men (18), but the mechanisms of the failed apoptosis remains unsettled (12). (d) Sperm DNA 
damage on the basis of oxidative stress. As this appears to be the major mechanism of sperm DNA 
damage it is the main focus in this study and outlined henceforth (9, 18). However, it should be 
recognized that these mechanisms are presumably interrelating and sperm DNA damage most likely 
arises from combinations of the proposed factors (4, 17, 18). 
 
1.2 Reactive oxygen species and oxidative stress 
Oxidative stress has been suggested as the major cause of reduced sperm quality (Reviewed in (10)) 
and corresponds to decreased fertility (5, 21). It is proposed that oxidative stress contributes to sperm 
DNA damage in 30-80% of infertile men (Reviewed in (5)).  
 
Oxidative stress is an excess of reactive oxygen species (ROS). As the name implies, ROS is a generic 
term for reactive molecules containing oxygen. The most important ROS in biology are free oxygen 
radicals. A free radical is a molecule that has gained an extra and consequently an unpaired electron. 
An example is when O2 becomes the superoxide anion O2
-
 with an extra unpaired electron. Free 
radicals are extremely reactive as they strive to get rid of their extra electron to other molecules. 
Examples of such reactions are oxidation of lipids in membranes, amino acids and carbohydrates in 
nucleic acids (22). In the normal energy metabolism of the cell ROS is generated. When energy is 
produced an enzymatic reduction of oxygen take place, and ROS are formed as byproducts (23). In 
homeostasis ROS play an important role, for example in destruction of infectious pathogens and 
intracellular signaling (23). Seminal ROS are desired at low levels to facilitate the capacitation in 
fertilization. If no fertilization takes place, ROS are built up over time and leads to sperm apoptosis. 
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The sperm is thereby easily cleared by the female immune system which prevents anti-sperm 
immunity (10).  
 
The human body has a natural antioxidant defense to take care of redundant ROS and maintain 
balance. However, when ROS exceed the inbuilt antioxidant defense the cells are exposed to oxidative 
stress. In oxidative stress, excessive ROS with their reactive properties can have destructive effects on 
the cell (23).    
 
1.3 Oxidative stress and spermatozoa 
In semen both spermatozoa and seminal leukocytes produce ROS. Leukocytes are probably the 
dominant source of ROS in semen (5, 24, 25). Seminal plasma has the greatest antioxidant power of 
all body fluids (10), however, the spermatozoa itself lacks antioxidants (4). It has been observed that 
ROS produced by sperm have a significantly stronger correlation with decreased sperm DNA integrity 
than ROS produced by leukocytes (25). Hence, sperm produced ROS is presumed to be more 
significant in correlation to infertility (5).  
 
Principally, oxidative stress may affect the spermatozoa in two ways. Firstly, oxidative stress impairs 
sperm motility, by ROS reacting with lipids in the sperm membrane through oxidation. The sperm 
membrane is especially vulnerable to ROS due to its high concentration of unsaturated fatty acids 
(10). A defect membrane causes loss of sperm motility and reduced ability to fuse with the oocyte 
(Reviewed in (5)). The mitochondria can also be directly damaged by ROS, which comprise energy 
production and leads to impaired motility (Reviewed in (5)). Secondly, oxidative stress directly 
damages sperm DNA. Protamination in spermatozoa of infertile men is often inadequate, i.e DNA is 
insufficiently stowed, and the DNA is therefore more vulnerable to oxidative stress (19). Oxidative 
stress can also induce caspase-mediated apoptosis, which degrades DNA (Reviewed in (5)).  
 
Sperm oxidative stress has been suggested to arise due to many different factors (Figure 1). The field 
of research in this particular subject is dispersed and studies have been conducted focusing on 
different factors using different methods. Several parameters have also been used as a measure of 
oxidative stress, for example sperm ROS, leukocytal ROS, testicular ROS and systemic ROS.  
 
One entity that summarizes several factors that might cause oxidative stress is lifestyle. Overweight 
has been linked with oxidative stress, it is proposed that adipose tissue increase the leukocyte ROS 
production and excessive adipose tissue in the groin region rises the temperature and thereby ROS 
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production (5, 26, 27). A high body mass index (BMI) has been linked to increased sperm DNA 
damage (27, 28) as well as to infertility (29-31). Hence, it is surprisingly that there is only one study , 
to the best of our knowledge, that has assessed the direct linkage between BMI and sperm oxidative 
stress (27). However, increased BMI has also been related to a decrease in testosterone levels (27, 30, 
32). Decreased testosterone levels has shown to be more prevalent in infertile men than in fertile men 
(33, 34). The causality between these parameters and male infertility is not fully unraveled (35, 36).  
 
Other examples of lifestyle factors causing oxidative stress are smoking and alcohol. Smoking has 
been correlated with just over a doubling in seminal ROS levels (37). Also smoking duration and 
quantity has shown to directly correspond to increased levels of ROS (38). Excessive alcohol 
consumption is known to increase systemic oxidative stress (39) and has been suggested to increase 
ROS levels within the testis (Reviewed in (5)).  
 
Another entity that influences ROS production is environmental factors. Pollutions and toxins lead to 
antioxidant depletion and increased testicular ROS levels (40). Especially heavy metal exposure has 
shown to be correlated with sperm oxidative stress (Reviewed in (5)).  
 
Chronic diseases, infections, inflammatory and autoimmune conditions can also interact with ROS 
production. It is proposed that in diabetes mellitus oxidative stress contributes to the well-known 
associated subfecundity (41). Infections also contribute to higher levels of ROS. Local genitourinary 
infections recruit leukocytes who produce ROS that interact with spermatozoa (42). In systemic 
infections systemic oxidative stress is generated and supposed to also strike the sperm while it afflicts 
the rest of the body (5). Varicocele has a well-established relation to infertility, and oxidative stress 
has lately been suggested to be the underlying mechanism (5). Varicocelectomy has shown to decrease 
seminal ROS levels (Reviewed in (43)). Another testicular event linked with oxidative stress is testis 
torsion which generates excessive ROS (44) contributing to the correlated decreased fertility (5).  
 
1.4 Assessment of reactive oxygen species in spermatozoa 
Despite the correlation between subfecundity and excessive ROS levels, infertile men are not 
routinely tested for sperm oxidative stress. There are different available analysis for sperm oxidative 
stress, for example a chemoluminescent procedure recommended by WHO (6). However, they are all 
costly, intricate and there is a lack of standardized measurements (5). If the prime obstacle, lack of 
standardized protocols, is solved, most consider oxidative stress testing beneficial in routine clinical 
practice (45). Recently, the nitro blue tetrazolium assay (NBT) traditionally used in diagnosis of 
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neutrophile produced ROS was applied in assessing sperm oxidative stress (21). It directly 
distinguishes between sperm and leukocyte ROS production and is relatively inexpensive and easy to 
set up (5, 21, 46). On the downside there is a shortage of published normal ranges (21). The first study 
to correlate sperm ROS production to sperm quality with NBT-assay was published in 2010, the 
results were promising, but due to the relatively small study group replications were suggested (21). A 
few replications have been made, showing similar results (27, 46). 
 
The NBT assay quantifies sperm produced ROS as a measure of sperm oxidative stress. Sperm are 
separated from plasma to exclusively evaluate sperm ROS. NBT solution is taken into the sperm 
cytoplasm and there sperm ROS converts the NBT to formazan (Figure 2). The more ROS the more 
formazan. The amount of formazan is then quantified by measuring the absorbance with a 
spectrophotometer. The absorbance is correlated to a standard curve, presenting the absorbance values 
at given concentrations of formazan crystals, and expressed as microgram of formazan per 10
7
 sperm. 
This as an indirect measure of sperm ROS production.     
 
1.5 Assessing sperm DNA damage  
Sperm DNA damage can be assessed with different methods, most commonly sperm chromatin 
structure assay (SCSA), terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and 
single cell gel electrophoresis (COMET) assay. Sperm chromatin structure assay is so far  the only 
sperm DNA integrity method that has demonstrated clear clinical cut-off levels in relation to fertility 
(9, 14, 16, 47). It quantifies spermatozoa with DNA strand breaks, is standardized (13), has a low 
intra- and inter-lab variety (9, 14) and can be used as an independent predictor of male fertility (47).  
Thus SCSA is starting to enter the field of routine sperm analyses.  
 
The principles of SCSA are that a low pH buffer is added to the semen sample. Some spermatozoa are 
more vulnerable than others to acid, and consequently their DNA denaturates. This vulnerability is 
thought to be caused by impaired chromatin structure and/or DNA strand breaks (17). The 
denaturation is therefore used as an indirect measure of sperm DNA disturbance (4). Denaturated cells 
are susceptible for an added fluorescent staining, in SCSA acridine orange (AO) is used. Due to the 
metachromatic properties of the staining, intact double DNA strands stain green and denaturated 
single DNA strands stain red. The ratio of red to total fluorescence intensity is determined by 
flowcytometry. Hence the result is expressed as percentage of denaturated DNA (red) to total DNA 
(total fluorescence) and called DNA fragmentation index (DFI) (4, 14). Even if WHO semen standard 
parameters are normal an increased DFI between 20-30% correspond to extended time to pregnancy 
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(4, 48). With a DFI >30% the chances of spontaneous conception (13) and pregnancy by intra uterine 
insemination (IUI) are minimal (4, 14). If one of the WHO semen parameters is abnormal, fertility is 
decreased already at DFI >10% (47).  
 
1.6 Objectives 
The primary objective was to study the correlation between sperm oxidative stress assessed with NBT 
assay and sperm DNA fragmentation index (DFI) assessed with SCSA in subfertile men. Secondly, 
the objective was to correlate these parameters to BMI as well as to the level of serum testosterone. 
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2 METHOD 
 
2.1 Study design 
Prospective study.  
     
2.2 Setting 
The study took place at Reproductive Medicine Center (RMC), Skåne University Hospital, Lund 
University from September 2012 to November 2012.  
 
2.3 Ethic approval 
The study was approved by the Ethics Committee at Lund University 2012-05-22, EPN number Dnr. 
2012/310, an amendment to Dnr. 2010/660. The men received no incentives, and participation was 
conditional based on written informed consent.  
 
2.4 Study population 
The study population consisted of subfertile men, who all had at least one previous sperm sample 
analysed at RMC. The cohort was based on an ongoing study at RMC (data to be published). 
According to the inclusion criteria, all participants were living in the Region Skåne and were aged 
between 18 and 50 years. They were diagnosed with male infertility according to International Criteria 
for Diseases (ICD-10) N46.9, between December 2006 and August 2012, and had all a sperm 
concentration below 20 million per millilitre (< 20 x 10
6
/mL). One hundred seventy-two participants 
were included in the study and obtainable 6
th
 of September 2012. From those, one study subject was 
excluded due to abuse of anabolic steroids. Additionally 55 study subjects were excluded due to 
azoospermia. Consequently invitations were sent to 116 persons. Reminders were sent in case of no 
reply after a period of 8-11 days. One of the invited men was deceased. The total answering frequency 
was 83% (96 subjects). Out of these 43 % (49 subjects) participated, 34% (39 subjects) refrained and 
7% (8 subjects) established contact but ended up not participating for different reasons. The rest, 17% 
(19 subjects), were non responders. Two participants were then excluded from the result due to 
testosterone treatment causing azoospermia (Figure 3).  
 
2.5 Analyses of semen samples 
Prior to semen collection participants were instructed to have an abstinence period, i.e. no ejaculation, 
of 2-4 days. Semen samples were produced at the clinic by masturbation, and liquefied in room 
temperature for 30 minutes (min). Within one hour post ejaculation, the conventional sperm 
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parameters were analysed and NBT assay was performed. Two hundred microliters (µL) of the semen 
sample were frozen for a later SCSA analyse. All analyses were performed at the RMC laboratory by 
experienced lab personnel. 
 
2.5.1 WHO sperm analysis 
The sperm samples were analysed, ejaculate volume (milliliter) and sperm concentration (10
6
/mL),  
according to the WHO guidelines (6). Sperm concentration > 15 x 10
6
/mL was considered normal (6). 
 
2.5.2 Nitro blue tetrazolium assay 
The NBT assay protocol was previously established at RMC, based on a published article describing 
the method (21). Two hundred microliters of raw semen were placed in an Eppendorf tube (Eppendorf 
AG, Hamburg, Germany). The sample was centrifuged in Eppendorf minispin (Eppendorf AG, 
Hamburg, Germany), 10 min at 500g (3.5x1000rpm) and washed with Dulbeccos's phosphate buffered 
saline (PBS) (JRH Biosciences, Lenexa, KN, USA), in order to separate sperm from seminal plasma. 
Thereafter the sample was divided into two aliquots of 100 µL.  NBT 0.01% stock was prepared 
dissolving one NBT tablet (Sigma Aldrich, St Louis, MO, USA) in MilliQ water (Millipore 
Corporation, Billerica, MA, USA) and then diluted 1:10 in PBS to create the working solution. An 
equal amount of the NBT working solution was added to each of the samples. The samples were 
incubated at 37ºC for 45 min, and thereafter centrifuged and washed twice to remove remaining NBT 
solution. The remaining product, a cell pellet with blue formazan crystals were released by 2 M 
potassium-hydroxide (KOH), KOH powder (Sigma Aldrich, St Louis, MO, USA). Dimethyl sulfoxide 
(Sigma Aldrich, St Louis, MO, USA) was added to the solvent. Subsequently 50 µL of the purple-
black solution was quantified using a spectrophotometer, Microplate reader Model ELx800 (Bio-Tek 
Instruments Inc, Winooski, VT, USA), measuring the absorbance at 630 nanometres with the use of 
Gen5 2.0 software (Bio-Tek Instruments Inc, Winooski, VT, USA). The mean absorbance from the 
two aliquots was calculated and supposed to be correlated to a standard curve. The standard curve 
produced by NBT solution reacting with superoxide anions, from the xanthine/xanthine oxidase 
system, forming formazan. The amount of formazan was weighed and its absorbance measured, and 
formazan mass versus absorbance plotted into a standard curve. Consequently sperm ROS production 
would be expressed as formazan per ten million spermatozoa.  
 
The standard curve was developed parallel to this study. However, no standard curve could be 
obtained in due time for our data analyses. Therefore, to enable intergroup comparison, we chose to 
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use the quote: absorbance divided with sperm concentration. This quote referred to as the NBT 
outcome. 
 
2.5.3 Sperm chromatin structure assay 
The SCSA was performed after a standard protocol (49) and analysed with dedicated software, SCSA-
Soft (SCSA Diagnostics Inc., Brookings SD, USA). Following conventional sperm analysis 200 µL of 
the raw semen samples, were frozen at -80°C. At the time for the analysis samples were thawed and 
diluted with TNE buffer (0.01 molar (M) Tris–HCl, 0.15 M NaCl and 1 milllimolar (mM) EDTA, pH 
7.4) to a sperm concentration of 6 x 10
6
/mL in 5 mL round bottom Falcon tubes (Becton Dickinson 
Biosciences, San José, CA, USA). Four hundred microliters of acid detergent (0.1% Triton X-100, 
0.15 M NaCl and 0.08 M HCl), pH 1.2, was then added to the samples. After exactly 30 seconds (sec), 
1.2 mL of acridine orange staining , purified acridine orange powder (Polysciences Inc., Warrington, 
PA, USA) solved in Millipore water, was added. Thus the denaturated single-stranded DNA stained 
red and intact double-stranded DNA stained green. The fluorescence were measured in a flow 
cytometer, FACS-calibur (Becton Dickinson, Franklin Lakes, NJ, USA), by CELLQuest software 
(Becton Dickinson, San Jose, CA, USA), 10 000 cells per sample. The flow cytometer was calibrated 
with a reference sample from a sperm donor. Data was analysed, shown in a scatter plot and then 
translated so that the ratio of red to total fluorescence intensity was visualized in a histogram. The 
result was expressed as percentage of denaturated DNA (red) over the total DNA (total fluorescence 
intensity), so called DNA fragmentation index (DFI). In this study, a DFI > 30% was considered as 
severe sperm DNA damage. 
 
2.6 Analyses of blood samples 
Blood samples were obtained by venepuncture for analysis of testosterone and luteinizing hormone 
(LH) (50). Blood were drawn between 7.30 and 10.00 am, after an overnight fast (51, 52). The sample 
tubes were transported within one hour and analysed by accredited analyses at Labmedicin Skåne, the 
university and regional laboratories in Region Skåne. If the participants had previous analyse results 
from RMC within a period of six months, no new blood samples were taken.  
 
Hypogonadism was defined biochemically. A testosterone below 12.0 nanomol per liter (nmol/L) (53) 
and/or lutenizing hormone above 10 international units per liter (IU/L) (54) were considered as 
hypogonadism. Clinical symptoms of male hypogonadism were not taken into account. 
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2.7 Body measurements 
The participants´ weight (kilograms) was measured, without shoes, trousers and heavy material in 
pockets. The body height (meters), already measured at a previous study appointment, was used for 
calculating BMI, kilograms per square meter (kg/m
2
).  BMI < 25 kg/m
2
 was considered normal 
weight, BMI 25-30 kg/m
2
 considered
 
overweight and BMI > 30 kg/m
2
 was considered obese (55). 
 
2.8 Additional data  
The participants were asked for ongoing testosterone treatment (yes/no) and smoking habits (regular 
smoker/ non-smoker). 
 
2.9 Statistical analysis 
Firstly, the NBT outcome, i.e the ratio between absorbance and sperm concentration, was correlated to 
the level of DFI. Eight samples were excluded due to azoospermia, as no quote could be obtained for 
the NBT outcome. The bivariate correlation analysis was carried out using Spearman´s rho. The same 
procedure was repeated with exclusion of NBT outcome values above one (to eliminate outliners), as 
well as with a subgroup analysis. The subgroup consisted of samples with sperm concentration > 2 x 
10
6
/mL. The correlation between the NBT outcome and the level of DFI for the total study population 
was also visualized in a linear regression plot. 
 
Secondly, the NBT outcome was related to the level of BMI. Here BMI was treated as a continuous 
variable as well as categorized into three groups; BMI < 25 kg/m
2
, BMI 25-30 kg/m
2
 and BMI > 30 
kg/m
2
. An univariate linear model was used for the comparison, with age, abstinence time and 
smoking as confounders in the model. Thereafter, the same analysis where performed for DFI in 
relation to BMI. Identical analysis, however with testosterone as a continuous variable and 
hypogonadism (yes/no) as categorized variable was also performed.  
 
Finally binary logistic regression was used to calculate odds ratios (OR) for the risk of having a DFI 
>30%; a) for the two higher BMI categories, i.e. BMI 25-30 kg/m
2
 and BMI > 30 kg/m
2
, in reference 
to the lowest BMI category, i.e. BMI < 25 kg/m
2
 and b) for the men with hypogonadism compared 
with the non-hypogonadistic men. These elaborations adjusted for age, abstinence time and smoking. 
 
Data were analyzed using the statistical software programme IBM SPSS Statistics version 21 (SPSS 
Inc., Chicago, IL, USA). Demographical and outcome data expressed as mean (± SD) or median 
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(range). Confidence intervals were set to 95% and a P-value < 0.05 was considered statistically 
significant. 
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3 RESULTS  
 
3.1 Descriptive and outcome data 
The cohort consisted of 47 men with a mean age of 34.8 years (SD±6.2). The mean abstinence time 
was 4.1 days (SD± 3.2). Twenty-five participants were overweight (BMI > 25 kg/m
2
). Two of the men 
were regular smokers. Concerning sperm quality the median sperm concentration was 1.1 x 10
6
/mL 
(range 0-18.2 x 10
6
/mL). The median DFI was 19% (range 7-48 %). Ten men had a DFI level above 
30%. The NBT outcome had a median of 0.036 (range 0.035-1.800). Sixteen of the men had a 
biochemically defined hypogonadism (Table I).   
 
3.2 Correlation between sperm oxidative stress and sperm DNA damage  
The outcome of the NBT and SCSA analyses showed a vague correlation which was not statistically 
significant (n = 39, r = 0.281, P = 0.084) (Figure 4). By exclusion of two outliners with extreme NBT 
outcome, the correlation was shown to be identical (n = 37, r = 0.288, P = 0.084) to the entire study 
group.  
 
The same analysis for correlating NBT outcome to DFI was also performed for a subgroup of men 
having a sperm concentration > 2 x 10
6
/mL due to a proposed cut off level for reliable NBT results 
(21). This correlation was, however, even weaker compared to the analysis of the entire group (n = 17, 
r = 0.171, P = 0.511).  
 
3.3 Sperm oxidative stress and sperm DNA damage in relation to BMI and 
testosterone/hypogonadism 
No relation was seen between NBT outcome and BMI, continuous as well as categorized. However, 
while there appears to be the possibility of a positive relation between DFI and categorized BMI this 
relation was not statistically significant (regression coefficient = 3.237, P = 0.119) (Table II).  
 
Neither testosterone level nor hypogonadism were related to NBT outcome or to level of DFI (Table 
III). These analysis were adjusted for age, abstinence time and smoking.  
 
3.4 Risk for sperm DNA damage on the basis of BMI as well as on the basis of hypogonadism 
Compared to the normal weighted men (BMI < 25 kg/m
2
) the overweighed (BMI > 25-30 kg/m
2
) had 
a fivefold increased risk for having a DFI > 30% (OR = 5.4, P = 0.131).  For the obese group (BMI > 
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30 kg/m
2
) the risk compared to the normal weighted men was nine fold (OR = 8.6, P = 0.070). 
However, none of these odds ratios were statistically significant (Table IV, Figure 5).   
 
Hypogonadism was related to a doubled increased risk of having a DFI exceeding 30% compared to 
the non-hypogonadistic group (OR = 2.2, P = 0.331) (Table IV), although not statistically significant. 
Male age, abstinence time and smoking habits were used as potential confounders in this model.  
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4 DISCUSSION  
 
The main finding of this study was that, although not statistically significant, levels of sperm oxidative 
stress were slightly associated with levels of sperm DNA damage in subfertile men. To the best of our 
knowledge, there is only one previous study that has assessed sperm oxidative stress with the NBT-
assay in relation to sperm DNA damage (21) and they demonstrated a statistically significant positive 
correlation between these parameters. The study of Tunc and colleges consisted of 36 infertile and 21 
fertile men, almost the same number of infertile as included in the present study. The weaker 
association in our study compared to Tunc´s, may be influenced by the method for evaluating sperm 
DNA damage (21). While Tunc used the TUNEL assay, the present study used SCSA and the two 
methods have been proposed to measure different aspects of sperm DNA damage (4). Although not 
shown, it cannot be neglected that one of the methods is more prone to detect sperm oxidative stress 
caused DNA damage compared to the other.   
 
Tunc´s study also supported the presumption that sperm oxidative stress can cause infertility. They 
showed a fourfold increase in sperm oxidative stress in infertile compared to fertile men, this positive 
correlation also reported by others (46). The study of Amarasekara and colleges had an infertile group 
double the size of our cohort and a fertile group of 30 men. Both studies also proposed two different 
NBT assay cut off levels for determination of fertile-infertile status. If a cut off level is defined, NBT 
assay can be used as a tool to sort out the men suffering from sperm oxidative stress caused infertility, 
which could be of important value in clinical practice. 
 
In the absence of a standard curve for the NBT assay, the comparison to other laboratory data could 
only be made regarding trends and not specific NBT assay outcome values. This unfortunate as we 
could not correlate our NBT outcome to the studies mentioned.  Hence, the proposed NBT assay cut 
off levels for determination of fertile-infertile status could not be related to (21, 46). Due to the lack of 
a fertile control group nor could we create our own cut off level.  
 
The weak association and the lack of a statistically significant result in this study may have several 
explanations. We acknowledge that this is a low power study and it is possible that a larger sample 
size had resulted in stronger correlations as well as statistic significance. In the NBT analysis the 
number of men was further diminished as the absorbance was divided with the sperm concentration 
and therefore eight azoospermic samples could not be included in the statistical analysis. 
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Another major contributing factor might be that the cohort had low median sperm concentration 
(range 0-18.2 x 10
6
/mL). This as one inclusion criteria was sperm concentration < 20 x 10
6
/mL. This 
was considered the lower limit for normal sperm concentration before the new guidelines of 15 x 
10
6
/mL (56). The Tunc-study suggested that the outcome of the NBT assay might be uncertain at low 
sperm concentration and proposed a lower limit of 2 x 10
6
/mL for analyses. This lower limit used in 
the Tunc-study but in the Amarasekara-study infertile men were included regardless of their sperm 
concentration (21, 46). As of this, we performed a subgroup analysis excluding all men with sperm 
concentrations < 2 x 10
6
/mL (64 % excluded). However, this analysis between sperm oxidative stress 
and sperm DNA damage ended up with a very limited number of men and presented even weaker 
results. Hence, no further analysis on the subgroup was executed.  
 
An unexpected finding, supporting a lower sperm concentration limit for reliable NBT results was that 
the azoospermic samples all produced absorbance results in the mid/lower range. Possible 
explanations to this mechanism could be sperm in the sample producing ROS, contamination of non-
sperm produced ROS and methodological errors. One possible error could be that with a small amount 
of spermatozoa there might be difficulties in removing all residual NBT-solution in the washing 
procedure. If the proposed lower limit is accurate, it is a limitation of the NBT-assay. However, set in 
the context of the chemoluminiescent assay, WHOs recommendation for assessing sperm oxidative 
stress, which needs at least a sperm concentration of 6-7 x 10
6
/mL (i.e. excluding 81-85% of the men 
in this study) this limitation seems acceptable.  
 
Concerning the SCSA measurements, the DFI results were in the higher range, as expected in a 
subfertile cohort and suitable when assessing a potential cause of sperm DNA damage. Nevertheless, 
our study showed a weak correlation between sperm oxidative stress and sperm DNA damage. Since 
there are several possible etiologies of sperm DNA damage, it cannot be neglected that our results 
could owe to a predominance of sperm DNA damage originating from other mechanisms than sperm 
oxidative stress. 
 
Due to the relatively low rate of participation (43 %) selection bias has to be considered. The reasons 
for not participating could be a recent involvement in other studies and/or ongoing treatment at RMC. 
As travel expenses and participation were not compensated, reason for not participating might be 
economical. It is also possible that the men with successful infertility treatment or spontaneous 
conception are more prone to participate than the men who are in for prolonged unsuccessful 
infertility treatment. This might have eliminated the men with severest infertility. On the other hand, it 
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is possible that the men with severe infertility are eager to try anything that might bring new insight 
into their situation. 
 
In regard to our secondary objective we found no association between sperm oxidative stress and 
BMI. To the best of our knowledge there is only one study that has assessed the correlation between 
sperm oxidative stress as measured with the NBT-assay and BMI (27). In contrast to our finding, this 
study including twice the number of men compared to our study showed a weak statistically 
significant positive correlation between sperm oxidative stress and BMI.  
 
In our study BMI was related to sperm DNA damage although not statistically significant. The obese 
men had about a nine fold increased risk for severe sperm DNA damage, although not statistically 
significant, compared to their normal weight counterparts. This was in line with previous published 
studies (27, 28). It seems evident that BMI and testosterone are interrelated (30, 32). The indifferent 
association between testosterone and sperm oxidative stress as well as sperm DNA damage seen in the 
present study was therefore not unexpected.  
 
The relation between BMI or testosterone and NBT outcome or DFI, may be influenced by additional 
factors than limited study population, low sperm concentrations, selection bias and methodological 
errors mentioned above. 
 
There is a risk of measurement bias, although minimization strategies were applied. For weight and 
length no self reporting was accepted. Blood samples were taken according to present clinical routine 
(50) and analysed by a accredited laboratory. Three study subjects had not been fasting for the 
testosterone sampling. This might reduce their testosterone levels, although there is only limited 
evidence and the present routine does not prescribe mandatory fasting (51, 52, 57). As testosterone 
treatment was self-reported there is always a risk for recollection bias. 
 
The potential confounders age, abstinence time and smoking were adjusted for. The cohort seems 
representative for the reproductive age, the mean age of the participants is close to the mean age for 
fathering a child in Sweden, reducing male age as a confounder (58). Abstinence time and smoking 
habits were self-reported, hence there is a risk of over/underestimations. There may also be other 
confounders, such as medications, infections, inflammations and lifestyle factors, however, these were 
not taken into consideration.  
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In conclusion, the weak association seen between sperm oxidative stress and sperm DNA damage, 
although not statistically significant, is in line with previous reports. Large scale clinical trials are 
warranted to further evaluate the NBT assay. In these trials, as opposed to this study, we recommend 
to include subjects independent of their sperm concentration and to also have a fertile control group. 
 
If sperm oxidative stress is established as a cause of male infertility and easily assessed, it could be 
included in routine infertility assessment and likely reduce the number of men diagnosed with 
idiopathic infertility. The hope for the future is to be able to sort out the men with sperm oxidative 
stress caused infertility, who would benefit from causative treatments, such as lifestyle changes and 
antioxidant therapy. This would lead to reduced suffering for the afflicted and reduced economic 
costs.  
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TABLES 
 
Table I. Demographic and outcome data, total study population. 
 
Parameters  
Patients, n 47 
Age, years, mean ± SD 34.8 ± 6.2 
Abstinence time, days, mean ± SD* 4.1 ± 3.2 
BMI, kg/m
2
, mean ± SD 26.1 ± 3.8 
BMI <25 kg/m
2
, n 22 
BMI 25-30  kg/m
2
, n 16 
BMI >30  kg/m
2
, n 9 
Smokers, n 2 
Sperm concentration, 10
6
/mL, median (range) 1.1 (0 -18.2) 
DFI, %, median (range) 19 (7 – 48) 
DFI >30 %, n 10 
NBT outcome, absorbance/sperm conc, median (range)** 0.036 (0.035 – 1.800) 
Testosterone, nmol/L, mean ± SD 16.3 ± 7.2 
LH, IU/L, mean  ± SD 6.0 ± 2.6 
Hypogonadism , n 16 
*    Three men excluded due to unknown abstinence time 
**  Eight men excluded due to azoospermia  
 
 
 
 
 
Table II. Relation between BMI (kg/m
2
) and NBT outcome (absorbance/sperm concentration), n = 38. 
Relation between BMI and DFI (%), n = 44. Adjusted for age, abstinence time and smoking. 
 
Parameters 
Regression 
coefficient 
P-value CI (95%) 
BMI and NBT outcome -0.005 0.699 -0.033 – 0.022 
BMI (<25, 25-30, >30) and NBT outcome -0.020 0.767 -0.157 – 0.117 
BMI and DFI 0.435 0.306 -0.414 – 1.283 
BMI (<25, 25-30, >30) and DFI 3.237 0.119 -0.868 – 7.343 
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Table III. Relation between testosterone (nmol/L) and NBT outcome (absorbance/sperm 
concentration), n = 38. Relation between testosterone (nmol/L) and DFI (%), n = 44. Adjusted for age, 
abstinence time and smoking. 
 
Parameters 
Regression 
coefficient 
P-value CI (95%) 
Testosterone and NBT outcome 0.006 0.410 -0.009 – 0.021 
Hypogonadism (yes/no)  and NBT 
outcome 
0.044 0.712 -0.197 – 0.285 
Testosterone and DFI -0.112 0.607 -0.549 – 0.324 
Hypogonadism (yes/no) and DFI 4.193 0.207 -2.421 – 10.806 
 
 
 
 
 
 
 
Table IV. The risk of having a DFI >30 %. Categorized DFI (%); DFI <30 (n= 37), DFI >30 (n=10). 
Categorized BMI (kg/m
2
); BMI <25 (n=22), BMI 25-30 (n=16), BMI >30 (n=9). Hypogonadism; yes 
(n=16), no (n=31). 
 
The risk of a DFI >30 OR P-value CI (95%) 
BMI 25-30 compared to BMI <25  5.4 0.131 0.607 – 47.95 
BMI >30 compared to BMI <25 8.6 0.070 0.837 – 88.839 
Hypogonadism compared to non-
hypogonadism 
2.2 0.331 0.456 – 10.299 
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Figure 5. 
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FIGURE TEXTS 
 
Figure 1. Causes of sperm oxidative stress. Processed by the authors after Kelton Tremellens Figure 1 
(5). 
Figure 2. Primary chemical reaction in the NBT-assay.  
Figure 3. Participants, the inclusion process.  
Figure 4. Linear regression with a trend line. DFI in correlation to NBT outcome.  N=39. 
Figure 5. Staple graph. The risk of a DFI >30 %. Categorized DFI (%); DFI <30 (n= 37), DFI >30 
(n=10). Categorized BMI (kg/m
2
); BMI <25 (n=22), BMI 25-30 (n=16). P-values in correlation to 
BMI <25. 
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ABBREVATIONS 
 
ART     Assisted reproductive techniques 
BMI     Body mass index 
CI    Confidence interval 
COMET   Single cell gel electrophoresis  
DFI     DNA fragmentation index  
g    Acceleration: Relative centrifugal force 
ICD-10   International criteria for diseases – 10 
IU    International unit 
KOH    Potassium hydroxide 
LH     Luteinizing hormone 
NBT     Nitro blue tetrazolium assay 
OR     Odds ratio 
PBS    Phosphate buffered saline 
r    Correlation coefficient 
RMC    Reproductive Medicine Center  
ROS     Reactive oxygen species 
rpm    Revolutions per minute 
SCSA   Sperm chromatin structure assay 
TUNEL   Terminal deoxynucleotidyl transferase mediated dUTP Nick End  
    Labeling assay 
WHO    World Health Organization 
